# Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

> **NCT00165750** · PHASE4 · TERMINATED · sponsor: **Eisai Korea Inc.** · enrollment: 40 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** DONEPEZIL HYDROCHLORIDE

## Key facts

- **NCT ID:** NCT00165750
- **Lead sponsor:** Eisai Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** 2008-08
- **Final completion:** 2008-11
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Lack of patients to enroll.
- **Last updated:** 2013-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165750, "Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00165750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*